Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 43NETWORK 5NIH 3INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 96Ovarian Neoplasms 54Endometrial Neoplasms 36Carcinoma, Ovarian Epithelial 22Fallopian Tube Neoplasms 19Neoplasms 11Uterine Cervical Dysplasia 9Papillomavirus Infections 7Recurrence 6Ovarian Cysts 6Vulvar Neoplasms 5Lymphatic Metastasis 5Uterine Neoplasms 4Peritoneal Neoplasms 4Gynecologic Cancer 4Colonic Neoplasms 4Pancreatic Neoplasms 3Malnutrition 3Hereditary Breast and Ovarian Cancer Syndrome 3Esophageal Neoplasms 3Endometrial Hyperplasia 3Carcinoma 3Breast Neoplasms 3Anxiety Disorders 3Stomach Neoplasms 2Radiation Injuries 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Patient Compliance 2Pain 2

Interventions

Vacuum Curettage 1Letrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Gestational Trophoblastic Disease × Gynecologic × Clear all
NCT05203562 2022-07-12

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Zagazig University

Phase 2/3 Unknown
200 enrolled
Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡